THIS SITE IS FOR UK HEALTHCARE PROFESSIONALS ONLY

Fictional patients used for illustrative purposes.

After Samantha started taking an SSRI at the start of this year, she found that it was affecting her sex drive,2 leading her to feel disconnected from her husband Robert.

It’s important for Samantha to find a treatment for her MDD that doesn’t affect her intimacy with her husband.

Sexual dysfunction:

Sexual dysfunction is common with serotonergic antidepressants, including SSRIs and SNRIs, and does not resolve in most patients²

MDD, major depressive disorder; SNRIs, serotonin–norepinephrine reuptake inhibitors; SSRIs, selective serotonin reuptake inhibitors.

Brintellix may help patients like Samantha who are experiencing sexual dysfunction with their current treatment2

In clinical trials a low rate of patients reported sexual dysfunction at 5-15 mg,*1,3 whereas the 20 mg dose was associated with an increase in sexual dysfunction compared to placebo.1 There have been reports of sexual dysfunction with doses below 20 mg during the post-marketing period.1

  • *Brintellix 15 mg is not available for use in the UK.1

For further information about Brintellix, including Tolerability, Special Warnings and Precautions and Contraindications, please visit the About Brintellix Section

about brintellix

Brintellix demonstrates greater improvement in SSRI-induced treatment-emergent sexual dysfunction compared with escitalopram2

  • Switching from an SSRI** to Brintellix was associated with significant clinical improvements in sexual functioning in patients diagnosed with MDD experiencing SSRI-related sexual dysfunction2
  • Improvements in sexual functioning with Brintellix were significantly greater than those with escitalopram at week 8 (p<0.05) as measured by change from baseline in the CSFQ-14 total score2
**citalopram, paroxetine, or sertraline
CSFQ-14, Changes in Sexual Functioning Questionnaire 14 items; SSRIs, selective serotonin reuptake inhibitors.
Fictional patients used for illustrative purposes.

For further information about Brintellix, including Tolerability, Special Warnings and Precautions and Contraindications, please visit the About Brintellix Section

about brintellix

Explore more in the sections below:

Adverse events should be reported.

Reporting forms and information can be found at http://www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
Adverse events should also be reported to Lundbeck Limited, Medical Information, on: 01908 638972 or Email: SafetyLuUnitedKingdom@lundbeck.com

References
  • Lundbeck. Brintellix. Summary of Product Characteristics GB and NI.
  • Jacobsen PL et al. J Sex Med 2015;12:2036–2048.
  • Baldwin DS et al. J Psychopharmacol 2016;30:242–252.
UK-BRIN-1285 | September 2023

This is a Lundbeck Limited developed and funded website intended for UK healthcare professionals only. This website contains promotional materials.

Please select the link below that is most relevant to you:

UK-BRIN-1539 | February 2024